72 related articles for article (PubMed ID: 7712471)
1. Use of the stress-inducible grp78/BiP promoter in targeting high level gene expression in fibrosarcoma in vivo.
Gazit G; Kane SE; Nichols P; Lee AS
Cancer Res; 1995 Apr; 55(8):1660-3. PubMed ID: 7712471
[TBL] [Abstract][Full Text] [Related]
2. Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment.
Dong D; Ko B; Baumeister P; Swenson S; Costa F; Markland F; Stiles C; Patterson JB; Bates SE; Lee AS
Cancer Res; 2005 Jul; 65(13):5785-91. PubMed ID: 15994954
[TBL] [Abstract][Full Text] [Related]
3. Use of the glucose starvation-inducible glucose-regulated protein 78 promoter in suicide gene therapy of murine fibrosarcoma.
Gazit G; Hung G; Chen X; Anderson WF; Lee AS
Cancer Res; 1999 Jul; 59(13):3100-6. PubMed ID: 10397251
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the endoplasmic reticulum chaperone GRP78/BiP by vomitoxin (Deoxynivalenol).
Yang GH; Li S; Pestka JJ
Toxicol Appl Pharmacol; 2000 Feb; 162(3):207-17. PubMed ID: 10652249
[TBL] [Abstract][Full Text] [Related]
5. GRP78 induction in cancer: therapeutic and prognostic implications.
Lee AS
Cancer Res; 2007 Apr; 67(8):3496-9. PubMed ID: 17440054
[TBL] [Abstract][Full Text] [Related]
6. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.
Fu Y; Li J; Lee AS
Cancer Res; 2007 Apr; 67(8):3734-40. PubMed ID: 17440086
[TBL] [Abstract][Full Text] [Related]
7. Expression of stress response protein glucose regulated protein-78 mediated by c-Myb.
Ramsay RG; Ciznadija D; Mantamadiotis T; Anderson R; Pearson R
Int J Biochem Cell Biol; 2005 Jun; 37(6):1254-68. PubMed ID: 15778089
[TBL] [Abstract][Full Text] [Related]
8. Suppression of stress protein GRP78 induction in tumor B/C10ME eliminates resistance to cell mediated cytotoxicity.
Sugawara S; Takeda K; Lee A; Dennert G
Cancer Res; 1993 Dec; 53(24):6001-5. PubMed ID: 8261413
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors.
Dong D; Dubeau L; Bading J; Nguyen K; Luna M; Yu H; Gazit-Bornstein G; Gordon EM; Gomer C; Hall FL; Gambhir SS; Lee AS
Hum Gene Ther; 2004 Jun; 15(6):553-61. PubMed ID: 15212714
[TBL] [Abstract][Full Text] [Related]
10. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development.
Dong D; Ni M; Li J; Xiong S; Ye W; Virrey JJ; Mao C; Ye R; Wang M; Pen L; Dubeau L; Groshen S; Hofman FM; Lee AS
Cancer Res; 2008 Jan; 68(2):498-505. PubMed ID: 18199545
[TBL] [Abstract][Full Text] [Related]
11. Cancer-inducible transgene expression by the Grp94 promoter: spontaneous activation in tumors of various origins and cancer-associated macrophages.
Reddy RK; Dubeau L; Kleiner H; Parr T; Nichols P; Ko B; Dong D; Ko H; Mao C; DiGiovanni J; Lee AS
Cancer Res; 2002 Dec; 62(24):7207-12. PubMed ID: 12499260
[TBL] [Abstract][Full Text] [Related]
12. Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78.
Wang JF; Bown C; Young LT
Mol Pharmacol; 1999 Mar; 55(3):521-7. PubMed ID: 10051536
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
[TBL] [Abstract][Full Text] [Related]
14. Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Zhang ZW; Guo YL
Cancer Gene Ther; 2004 Apr; 11(4):263-72. PubMed ID: 14963492
[TBL] [Abstract][Full Text] [Related]
15. FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo.
Koga S; Hirohata S; Kondo Y; Komata T; Takakura M; Inoue M; Kyo S; Kondo S
Anticancer Res; 2001; 21(3B):1937-43. PubMed ID: 11497281
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth JA; Fang B
Cancer Res; 2000 Oct; 60(19):5359-64. PubMed ID: 11034071
[TBL] [Abstract][Full Text] [Related]
17. Differential interaction of molecular chaperones with procollagen I and type IV collagen in corneal endothelial cells.
Ko MK; Kay EP
Mol Vis; 2002 Jan; 8():1-9. PubMed ID: 11815750
[TBL] [Abstract][Full Text] [Related]
18. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
Gu J; Andreeff M; Roth JA; Fang B
Gene Ther; 2002 Jan; 9(1):30-7. PubMed ID: 11850720
[TBL] [Abstract][Full Text] [Related]
19. Constitutive and stress-inducible expression of the endoplasmic reticulum heat shock protein 70 gene family member, immunoglobulin-binding protein (BiP), during Xenopus laevis early development.
Miskovic D; Heikkila JJ
Dev Genet; 1999; 25(1):31-9. PubMed ID: 10402670
[TBL] [Abstract][Full Text] [Related]
20. A novel nonviral cytoplasmic gene expression system and its implications in cancer gene therapy.
Chen X; Li Y; Xiong K; Xie Y; Aizicovici S; Snodgrass R; Wagner TE; Platika D
Cancer Gene Ther; 1995 Dec; 2(4):281-9. PubMed ID: 8548582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
